S-3
for 24 h at room temperature (R.T.). And then, the mixture was filtered, concentrated and precipitated into a cold mixture of diethyl ether/methanol (10/1, v/v) twice to gain the crude ROS-sensitive macroinitiator mPEG 45 -TK-NH 2 . Then, the crude products were purified by a column chromatography (1.26 g, 58%).
Synthesis of mPEG 45 -TK-Ce6.
Ce6 (0.54 mmol, 0.32 g), dicyclohexylcarbodiimide (DCC, 1.78 mmol, 0.37 g), and N-hydroxysuccinimide (NHS, 1.78 mmol, 0.21 g) were dissolved in 20 mL CH 2 Cl 2 .
After reacting for 6 h, the solution of Ce6 was dropwise added into 20 mL CH 2 Cl 2 containing mPEG-TK-NH 2 (0.49 mmol, 1.1 g) under stirring, and further reacted for 24 h at R.T. And then, the mixture was filtered, concentrated and precipitated into a cold mixture of diethyl ether/methanol (10/1, v/v) twice to gain the ROS-sensitive mPEG 45 -TK-Ce6 (1.09 g, 78.6%).
Synthesis of PLA homopolymer and FITC-PLA.
PLA polymer was synthesized using 10-hydroxydecanoic acid as the initiator under the catalysis Sn(Oct) 2 . In a typical procedure, anhydrous 10-hydroxydecanoic acid (0.4 mmol, 0.075 g), L-lactide (13.9 mmol, 2.0 g) were dissolved in anhydrous methylbenzene (15 mL) in a fresh flamed flash. Stirring for 30 min at 80 °C until the solid is completely dissolved, then Sn(Oct) 2 (0.04 mmol, 16 mg) was added to the mixture. The reaction was carried on at 80 °C for 3 h. Then benzoic acid (0.6 mmol, 73 mg,) was added to terminate the reaction, and the mixture was concentrated and precipitated into a cold diethyl ether/methanol mixture (10/1, v/v) twice. The product was dried under vacuum at to obtain the product with a yield of 69.1% (1.38 g), and According to the method mentioned above, the DLCs of Ce6 and platinum were 7.5 ± 0.59% and 4.31 ± 0.36%, and the corresponding EEs were 71.2% and 56.8%.
The generation of ROS in vitro. into the second mammary fat pad of mice, when tumor volumes reach about 100 mm 3 , mice were used for subsequent experiments.
Pharmacokinetic studies.
Female ICR mice (6-weeks-old) were intravenously (i.v.) injected with free cisplatin and TCNP Pt (2.0 mg platinum per kg mouse weight, n = 3). At the predetermined timepoints, blood samples were collected for ICP-MS analysis.
Statistical Analysis.The statistical significance of treatment outcomes was assessed using a Student's t-test; *p < 0.05 and **p < 0.01 were considered statistically significant in all analyses. Figure 5C . Table S1 . Pharmacokinetic parameters of these formulations after intravenous administration (n = 3 per group).
